Advanz Pharma   Report issue

Contributed to NME For profit Phase 1 Phase 2 Phase 3 Phase 4
Founded: Mississauga Canada (2010)
Status: No NME R&D (2010)

Organization Overview

First Clinical Trial
2010
NCT00867230
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2017

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

ADVANZ PHARMA | at the request of Concordia Laboratories Inc. | CONCORDIA | Concordia Healthcare | Concordia Laboratories Inc. | CONCORDIA LABS INC | Concordia Pharmaceuticals | Concordia Pharmaceuticals, Inc | Concordia Pharmaceuticals Inc., Barbados | CONCORDIA PHARMS INC